Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis

Inoue K, 2004, Pathological analyses of long-term intracoronary Palmaz-Schatz stenting: is its efficacy permanent?, Cardiovasc Pathol., 13, 109, 10.1016/S1054-8807(03)00132-7

Hasegawa K, 2006, Histopathological findings of new in-stent lesions developed beyond five years., Catheter Cardiovasc Interv., 68, 554, 10.1002/ccd.20787

Takano M, 2009, Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography., J Am Coll Cardiol., 55, 26, 10.1016/j.jacc.2009.08.032

Nakazawa G, 2011, The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents., J Am Coll Cardiol., 57, 1314, 10.1016/j.jacc.2011.01.011

Nakazawa G, 2009, One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis., J Am Coll Cardiol Img., 2, 625, 10.1016/j.jcmg.2009.01.011

Kang S, 2011, Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation., Circulation., 123, 2954, 10.1161/CIRCULATIONAHA.110.988436

Yonetsu T, 2012, Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography., Am J Cardiol., 110, 933, 10.1016/j.amjcard.2012.05.027

Yonetsu T, 2012, Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry., Circ Cardiovasc Imaging., 5, 660, 10.1161/CIRCIMAGING.112.976167

Park S, 2012, In-stent neoatherosclerosis: a final common pathway of late stent failure., J Am Coll Cardiol., 59, 2051, 10.1016/j.jacc.2011.10.909

Kim U, 2010, The initial extent of malapposition in ST-elevation myocardial infarction treated with drug-eluting stent: the usefulness of optical coherence tomography., Yonsei Med J., 51, 332, 10.3349/ymj.2010.51.3.332

Cutlip DE, 2007, Clinical end points in coronary stent trials: a case for standardized definitions., Circulation., 115, 2344, 10.1161/CIRCULATIONAHA.106.685313

Gonzalo N, 2009, Optical coherence tomography patterns of stent restenosis., Am Heart J., 158, 284, 10.1016/j.ahj.2009.06.004

Prati F, 2010, Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis., Eur Heart J., 31, 401, 10.1093/eurheartj/ehp433

Lee SJ, 2011, Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study., Clin. Cardiol., 34, 633, 10.1002/clc.20960

Joner M, 2008, Endothelial cell recovery between comparator polymer-based drug-eluting stents., J Am Coll Cardiol., 52, 333, 10.1016/j.jacc.2008.04.030

Stone GW, 2010, Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease., N Engl J Med., 362, 1663, 10.1056/NEJMoa0910496

Serruys PW, 2010, Comparison of zotarolimus-eluting and everolimus-eluting coronary stents., N Engl J Med., 363, 136, 10.1056/NEJMoa1004130

Lee CW, 2010, Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation., J Am Coll Cardiol., 55, 1936, 10.1016/j.jacc.2009.10.077